Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bluestar Adisseo CoSHSE:600299 -0.88%85 EBITDA Margin % is 9.00% as of Mar. 2026, which is 62% below its 10-year median of 23.74. GuruFocus rates SHSE:600299 with a GF Score™ of 85/100 and a GF Value™ of ¥11.47 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,578 Chemicals companies, Bluestar Adisseo Co ranks worse than 56.84% on this metric.
Bluestar Adisseo Co (SHSE:600299) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bluestar Adisseo Co EBITDA Margin % Related Terms
Bluestar Adisseo Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Bluestar Adisseo Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600299 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Bluestar Adisseo Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bluestar Adisseo Co EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bluestar Adisseo Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bluestar Adisseo Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bluestar Adisseo Co (SHSE:600299) has a EBITDA Margin % of 9.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bluestar Adisseo Co and its competitors. This is 62% below median its historical median of 23.74. Over the past decade, Bluestar Adisseo Co's EBITDA Margin % has ranged from 8.03 to 37.79. According to the industry distribution chart, Bluestar Adisseo Co ranks #897 out of 1578 companies in the Chemicals industry, placing it in the top 56.8%.
Is Bluestar Adisseo Co's EBITDA Margin % too high?
Bluestar Adisseo Co's current EBITDA Margin % of 9.00% is 62% below median its 10-year median of 23.74. Over the past 10 years, this metric has ranged from a low of 8.03 to a high of 37.79. The Chemicals industry median EBITDA Margin % is 9.64. Bluestar Adisseo Co's value of 9.00% is 6.6% below this industry median. Based on the distribution chart, Bluestar Adisseo Co ranks #897 out of 1578 companies in the Chemicals industry, which is below the industry midpoint. Overall, Bluestar Adisseo Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bluestar Adisseo Co's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Bluestar Adisseo Co ranks #897 out of 1578 companies for EBITDA Margin %. This places Bluestar Adisseo Co in the lower half of its industry. The industry median EBITDA Margin % is 9.64. Bluestar Adisseo Co's value of 9.00% is 6.6% below this benchmark. Historically, Bluestar Adisseo Co's own EBITDA Margin % has ranged from 8.03 to 37.79 over the past decade. While the company's 10-year median is 23.74 vs. the industry median of 9.64, Bluestar Adisseo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bluestar Adisseo Co's current EBITDA Margin % of 9.00% is 6.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bluestar Adisseo Co and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bluestar Adisseo Co's current EBITDA Margin % is 9.00%, which is 62% below median its own 10-year median of 23.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluestar Adisseo Co stock overvalued right now?
Based on GuruFocus' analysis, Bluestar Adisseo Co (SHSE:600299) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥11.47, compared to a current price of ¥7.89 — trading 31.2% below its estimated fair value. The current EBITDA Margin % is 9.00%, which is 62% below median its 10-year median of 23.74 and 6.6% below the Chemicals industry median of 9.64. Bluestar Adisseo Co's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bluestar Adisseo Co (SHSE:600299), the current EBITDA Margin % is 9.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bluestar Adisseo Co (SHSE:600299) Overvalued in 2026?
Based on GuruFocus' analysis, Bluestar Adisseo Co stock appears to be undervalued.
The current stock price of ¥7.89 is trading 31.2% below its estimated GF Value™ of ¥11.47.
GuruFocus considers Bluestar Adisseo Co to be Significantly Undervalued.
Key valuation signals for SHSE:600299:
EBITDA Margin %: 9.00% (62% below median its 10-year median of 23.74)
GF Value™: ¥11.47 vs. price of ¥7.89 (31.2% below fair value)
Industry Position: 6.6% below the Chemicals median (#897 of 1578)
No single metric tells the full story. See the SHSE:600299 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bluestar Adisseo Co is a China-based company engaged in the business of development, production, and sale of animal nutrition additives. Its products are Roddy US, Michael dimensional, ROVABIO, Hillier selenium, AdiSodium, and others. In addition, it also provides the customers with services such as Precision Nutrition Analysis service, Liquid Addition Solution, and E-lab service. The company's products are sold in China and other international countries.
85GF Score
Get the complete analysis for SHSE:600299
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600299 has been successfully added to your 
